Abstract: A series of novel tetrabromo-bis(substituted benzyl)cycloalkanones have been synthesized through a rapid, simple, and efficient methodology in an excellent isolated yield and characterized via IR, NMR ( 1 H-, 13 C-NMR, DEPT 135, DEPT 90) and mass spectrometry. All compounds were assayed for their in vitro antimicrobial activities against eight bacteria and five fungi. They showed stronger antibacterial than antifungal activities. Compounds 4c, 4d and 4i, containing a methoxy or chloro substituent on the para or meta position of the phenyl ring, showed comparable minimum inhibitory concentration (MIC) values to those of the standard antibiotics streptomycin and tetracycline. Among all the tested compounds, 4i exhibited good to moderate antifungal activity against all the tested fungal strains used.
INTRODUCTION
In the past few decades, the incidence of serious antimicrobial infection has increased dramatically 1 due to the problem of multi-drug resistant microorganisms that has reached alarming levels around the world. For the treatment of microbial infections, the synthesis of new anti-infectious compounds has become a critical need. The organohalogen compounds have received much attention due to their important use in the field of medicinal and agro-chemistry. [2] [3] [4] A survey of the literature also revealed that different kinds of bis(substituted benzylidene)cycloalkanones, including organohalogen compounds, have been used for the treatment of the central nervous system, cardiovascular and obesity diseases, 718 RAHMAN, ALAM and KADI and also showed antibacterial, 5 antifungal, 5 anti-angiogenic, 6, 7 quinine reductase inducer, 8 cytotoxic, 9, 10 and cholesterol-lowering activity. 11 In 1980, Hoeve and Wynberg 12 prepared tetrabromo-di-m-anisalcyclopentanone from 2,5-dibenzylidenecycloalkanones using bromine in chloroform in a 47 % yield. Later, in 1988, Desiraju and Kishan 13 used the same starting material and obtained dibromo derivatives in which the bromine addition occurred on the methylene carbon of 2,5-dibenzylidenecycloalkanones. In the present study, we have synthesized and performed antimicrobial evaluation of a series of tetrabromo-bis(substituted benzyl)cycloalkanone analogues (4a-j). The structures of the new compounds were established by IR, NMR ( 1 H-, 13 C-, DEPT 135 and DEPT 90) and mass spectrometry.
EXPERIMENTAL

Chemistry
General. Melting points were recorded on a Fisher-Jones melting point apparatus and are uncorrected. IR spectra were obtained on an FTIR-300E (Jasco Corporation, Tokyo, Japan) in KBr disc. 1 H-NMR (250 MHz) and 13 C-NMR (62.5 MHz) spectra were recorded on a Bruker 250 spectrometer (Bruker, USA) in CDCl 3 with TMS as an internal standard. ESI--MS were measured on an LCQ advantage-trap mass spectrometer (Thermo Finnigan, San Jose, CA, USA).
Synthesis of bis(substituted benzyl)cycloalkanones 3a-j
The bis(substituted-benzyl)cycloalkanones were obtained by the cross-aldol condensation of substituted aldehydes with cycloalkanones in the presence of sodium acetate-acetic acid, Scheme 1. 14 
Synthesis of tetrabromo-bis(substituted benzyl)cycloalkanones 4a-j
The tetrabromo-bis(substituted benzyl)cycloalkanones (4a-j) were prepared by adding a Br 2 solution (2 mmol) in dioxane (10 mL) dropwise over 10 min to a stirred solution of the respective bis(substituted benzyl)cycloalkanone (3a-j, 1 mmol) in dioxane (20 mL). The stirring was continued for 3-4 h. The completion of the reaction was monitored by thin layer chromatography (TLC). The solvent was evaporated and the dry residue subjected to column chromatography (n-hexane/dichloromethane, 1:1), which afforded the respective compound 4a-j as a white solid.
Data of synthesized compounds are given in Supplementary material. The minimum inhibitory concentrations (MICs) of compounds 4a-j were tested by the two-fold serial dilution method. 15 The test compounds 4a-j were incorporated into Luria-SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF ORGANOHALOGENS
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-Broth medium to obtain a concentration of 1,000 μg ml -1 and serially diluted to a concentration in the range from 500 to 7.8 μg ml -1 . A standardized suspension (10 μl) of each of the tested organism (10 8 CFU ml -1 ) was transferred to each tube and incubated at 37 °C for 24 h. Control tubes containing only bacterial suspensions were also incubated at 37 °C for 24 h. The lowest concentrations of the test samples that did not show any growth of the tested organism after macroscopic evaluation were determined as the MICs. Potato dextrose agar (PDA) medium was used as the basal medium for the antifungal activity assay, which was performed by disc diffusion method. 16 Sterile Whatman No. 1 paper discs (6 mm diameter) were pierced in agar plates, equidistant and near the border, where 10 μl of compounds 4a-j (200 μg disc -1 ) were applied. A disc of fungal inoculum 6 mm in diameter was removed from the pre-grown cultures of all the tested fungal strains and placed upside down in the center of the Petri dishes. The plates were incubated at 28 °C for 5-7 days, the time in which the growth of the control would have reached the edges of the plates. Discs with CHCl 3 and nystatin were used as negative and positive controls, respectively. The inhibitory activity was measured (in mm) as the diameter of the observed inhibition zones.
_______________________________________________________________________________________________________________________
Available online at www.shd.org.rs/JSCS/ The minimum inhibitory concentration (MIC) was determined by the two-fold dilution method, 15 against B. cinerea, R. solani, F. oxysporum, S. sclerotiorum and P. capsici. Samples were dissolved in CHCl 3 accordingly with their respective known weight. These solutions were serially diluted with CHCl 3 and were added to PDA to final concentrations of 500, 250 125 and 62.5, 31.2, 15.6 and 7.8 μg ml -1 , respectively. A 10 μl spore suspension of each test strain was inoculated in test tubes in PDA medium and incubated for 2-7 days at 28 °C. The control tubes containing PDA medium were inoculated only with fungal suspension. The minimum concentration at which no visible growth was observed was defined as the MIC, which was expressed in μg ml -1 .
RESULTS AND DISCUSSION
Chemistry
The synthetic route to the tetrabromo-bis(substituted benzyl)cycloalkanones (4a-j) are outlined in Scheme 1. The compounds 4a-j were obtained from the intermediate compounds 3a-j, respectively, in excellent yields (70-93 %). The structures of the newly synthesized compounds were established based on their IR, 1 H-NMR, 13 C-NMR, DEPT 135, DEPT 90 and mass spectral data. IR spectra of compounds 4a-j showed an absorption peak in the 1660-1681 cm -1 region, indicating the presence of a carbonyl (>C=O) group. In the 1 H-NMR spectra, the characteristic benzylic protons of compounds 4a-j appeared as a singlet at 5.50--6.03 ppm. The aliphatic protons of the cyclopentanone ring of compounds 4a-e appeared as two AB-quartets at around 3.28-3.32 and 2.37-2.42 ppm equivalent to two protons, respectively. On the other hand, the six protons of the cyclohexanone ring of compounds 4f-j were observed as triplets of a doublet at 2.99-3.07 ppm and two multiplets at around 2.14-2.46 and 1.90-2.03 ppm equivalent to two, three and one proton(s), respectively. The aromatic protons of the phenyl groups of compounds 4a-j appeared in usual way. The methyl protons of compounds 4b and 4g were observed as a singlet at 2.35-2.36 ppm, whereas the methoxy protons of compounds 4d and 4i appeared as a singlet at 3.81-3.82 ppm. In the 13 C-NMR spectra of compounds 4a-j, the characteristics carbonyl carbons and benzylic carbons appeared at 197.77-198.57 ppm and 51.40-55.30 ppm, respectively. In addition, the α-carbons were observed in the range of 63.95--67.98 ppm. In summary, all the newly synthesized compounds exhibited satisfactory spectral data consistent with the proposed structures. In addition, electron spray ionization mass spectra (ESI-MS) of 4a-j showed a metastable ion peak as [M( 79 Br)+H] + (100 %) in the positive mode along with other isotopic peaks.
Antibacterial activity
The in vitro antibacterial activities of the novel compounds 4a-j were assayed against three 
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(MIC / μg ml -1 ) was determined by the serial dilution method 15 for all the compounds and compared with the controls (streptomycin and tetracycline).
The MIC values of the tested compounds are presented in Table I , from which it can be seen that all the tetrabromo-bis-benzylcycloalkanone analogues (4a-j) showed antibacterial activity against both the Gram-positive and Gram-negative bacteria. Among the tested compounds, compound 4i exhibited the highest activity against both Gram-positive and Gram-negative strains, followed by compounds 4c and 4d. The MIC values of compounds 4i, 4c and 4d are almost comparable to those of the standard drugs used in the present study against all bacterial strains. Structure-activity relationships (SAR) may be explained briefly as follows: the ring size of cycloalkanones has no strong effect on the antibacterial activity, whereas the unsubstituted compounds (4a and 4f) showed lower activity than the substituted compounds (4b-d and 4g-j). Introduction of hydrophilic substituents (halogen, OMe) at the R 2 or R 1 position resulted in better activity than the hydrophobic substituent (CH 3 ). Among the compounds containing halogen substitution at the phenyl ring, the chlorine analogue (4c) showed better antibacterial activity than the fluorine or bromine analogues (4e, 4h and 4j).
Antifungal activity
The newly synthesized novel 4a-j were evaluated for their in vitro antifungal activities against five fungal strains, i.e., B. cinerea, R. solani, F. oxysporum, S. sclerotiorum and P. capsici by disc diffusion methods. The inhibition zones of the synthesized compounds were measured at a dose of 200 μg disc -1 and nystatin, a positive control, were evaluated at a dose of 30 μg disc -1 . As presented in Table  II , among the all tetrabromo-bis-benzylcycloalkanone derivatives (4a-j) tested, 5 compounds inhibited the growth of some fungal strains. In detail, compound 4i _______________________________________________________________________________________________________________________ 722 RAHMAN, ALAM and KADI showed good to moderate activity against all the tested fungal strains, while compounds 4d and 4j exhibited moderate activity against R. solani and F. oxysporum. Compounds 4f and 4h demonstrated moderate activity against one bacterial strain only. Compounds 4a-c, 4e and 4g showed no activity against all the tested fungal strains. Therefore, the minimum inhibitory concentrations (MICs) of compound only 4i against B. cinerea, R. solani, F. oxysporum, S. sclerotiorum, and P. capsici were determined and found MIC values of 125, 31.2, 31.2, 125 and 250 µg ml -1 , respectively, were found (Table III) . 
CONCLUSIONS
In this paper, an efficient synthesis of novel tetrabromo-bis(substituted benzyl)cycloalkanone derivatives and their antimicrobial activities against eight bacterial and five fungal strains were presented. All the tetrabromo-bis(substituted benzyl)cycloalkanone analogues showed potent antibacterial activity compared to their antifungal activity. Compounds 4i, 4c and 4d, having a methoxy-or chloro-substituent on the para or meta position of the phenyl ring exhibited strong activity against all the tested bacterial strains. Hydrophilic substitution on the phenyl ring resulted in a better antibacterial activity than that of hydrophobic substitution. Among all the tested compounds, 4i exhibited good antifungal activity against R. solani and F. oxysporum. The potential antimicrobial activity of compounds 4i, 4c and 4d would be helpful in synthesis of a huge number of tetrabromo-bis(substituted benzyl)cycloalkanone analogues for extensive antimicrobial studies, which could be used to develop more suitable drug candidates.
SUPPLEMENTARY MATERIAL
Аnalytical and spectral data of synthesized compounds are available electronically from http://www.shd.org.rs/JSCS/, or from the corresponding author on request.
